Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
Open Access
- 5 February 2021
- Vol. 10 (2), 325
- https://doi.org/10.3390/cells10020325
Abstract
Pyruvate dehydrogenase kinase 1 (PDK1) blockade triggers are well characterized in vitro metabolic alterations in cancer cells, including reduced glycolysis and increased glucose oxidation. Here, by gene expression profiling and digital pathology-mediated quantification of in situ markers in tumors, we investigated effects of PDK1 silencing on growth, angiogenesis and metabolic features of tumor xenografts formed by highly glycolytic OC316 and OVCAR3 ovarian cancer cells. Notably, at variance with the moderate antiproliferative effects observed in vitro, we found a dramatic negative impact of PDK1 silencing on tumor growth. These findings were associated with reduced angiogenesis and increased necrosis in the OC316 and OVCAR3 tumor models, respectively. Analysis of viable tumor areas uncovered increased proliferation as well as increased apoptosis in PDK1-silenced OVCAR3 tumors. Moreover, RNA profiling disclosed increased glucose catabolic pathways—comprising both oxidative phosphorylation and glycolysis—in PDK1-silenced OVCAR3 tumors, in line with the high mitotic activity detected in the viable rim of these tumors. Altogether, our findings add new evidence in support of a link between tumor metabolism and angiogenesis and remark on the importance of investigating net effects of modulations of metabolic pathways in the context of the tumor microenvironment.Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG 18893)
This publication has 35 references indexed in Scilit:
- The Emerging Hallmarks of Cancer MetabolismCell Metabolism, 2016
- The role of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET/CT in the prognosis of epithelial ovarian cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2013
- Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor AngiogenesisPLOS ONE, 2012
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Why do cancers have high aerobic glycolysis?Nature Reviews Cancer, 2004
- Lactate in Solid Malignant Tumors: Potential Basis of a Metabolic Classification in Clinical OncologyCurrent Medicinal Chemistry, 2004
- Lactate: mirror and motor of tumor malignancySeminars in Radiation Oncology, 2004
- Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-d-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without ChemotherapyJournal of Clinical Oncology, 2002